Social Anxiety Disorder News and Research RSS Feed - Social Anxiety Disorder News and Research

Bipolar remission influenced by anxiety and OCD

Bipolar remission influenced by anxiety and OCD

Anxiety disorders and obsessive compulsive disorder may reduce the likelihood of achieving remission for patients with bipolar disorder, study findings indicate. [More]
Elsevier launches Open Access, online-only journal Internet Interventions

Elsevier launches Open Access, online-only journal Internet Interventions

Elsevier, a world-leading provider of scientific, technical and medical (STM) information products and services, is pleased to announce the launch of the Open Access, online-only journal Internet Interventions. [More]
Publication provides update on the origins and causes of anxiety disorders

Publication provides update on the origins and causes of anxiety disorders

Anxiety disorders are not uncommon and are often 'comorbid' with other forms of mental disorders. This publication provides an update on the origins and the causes of anxiety disorders and their related symptoms. [More]
Study shows anxiety-promoting parental behaviors affect children

Study shows anxiety-promoting parental behaviors affect children

Parents with social anxiety disorder are more likely than parents with other forms of anxiety to engage in behaviors that put their children at high risk for developing angst of their own, according to a small study of parent-child pairs conducted at Johns Hopkins Children's Center. [More]
Social threat reveals self-esteem mismatch in social anxiety disorder adolescents

Social threat reveals self-esteem mismatch in social anxiety disorder adolescents

Adolescents with social anxiety disorder have a marked discrepancy between implicit and explicit self-esteem following a social threat, such as being asked to give a speech, the results of a German study indicate. [More]
FDA approves Mylan's ANDA for Venlafaxine HCl ER Capsules to treat depressive, anxiety disorder

FDA approves Mylan's ANDA for Venlafaxine HCl ER Capsules to treat depressive, anxiety disorder

Mylan Inc. today announced that its subsidiary Mylan Pharmaceuticals Inc. has received final approval from the U.S. Food and Drug Administration for its Abbreviated New Drug Application for Venlafaxine Hydrochloride Extended-release Capsules, 37.5 mg (base), 75 mg (base) and 150 mg (base), the generic version of Wyeth's Effexor XR Capsules, which are used in the treatment of major depressive disorder and social anxiety disorder. [More]
Smokers with anxiety disorders less likely to quit smoking

Smokers with anxiety disorders less likely to quit smoking

Researchers may have pinpointed a reason many smokers struggle to quit. According to new research published in the journal Addiction, smokers with a history of anxiety disorders are less likely to quit smoking. The study, conducted by the University of Wisconsin Center for Tobacco Research and Intervention (UW-CTRI), offered free coaching and medications to smokers in Madison and Milwaukee. [More]
Flexible treatment delivery intervention in primary care reduces symptoms of anxiety: Study

Flexible treatment delivery intervention in primary care reduces symptoms of anxiety: Study

An intervention in primary care settings that allowed a choice of cognitive behavior therapy, medication, or both, along with computer-assisted treatment support for patients with common anxiety disorders, resulted in greater improvement in anxiety symptoms and functional disability compared to usual care, according to a study in the May 19 issue of JAMA, a theme issue on mental health. [More]
Report on CNS disorders market from Research and Markets

Report on CNS disorders market from Research and Markets

Research and Markets has announced the addition of the "The CNS Market Outlook to 2014: Competitive Landscape, Pipeline Analysis and Growth Opportunities" report to their offering. [More]
New clinical study: CeNeRx BioPharma's CXB722 has potential as novel anxiolytic

New clinical study: CeNeRx BioPharma's CXB722 has potential as novel anxiolytic

CeNeRx BioPharma, Inc., a clinical stage company developing and commercializing innovative treatments for diseases of the central nervous system, today reported that a new clinical study shows that its investigational compound CXB722 has potential as a novel anxiolytic, demonstrating a significant effect on both endocrine and cardiovascular biomarkers associated with stress. [More]
Opportunities and challenges in the psychiatric disease market

Opportunities and challenges in the psychiatric disease market

Research and Markets has announced the addition of Decision Resources, Inc.'s new report "The Psychiatric Disease Pipeline: A Strategic Review" to their offering. [More]
Researchers find link between altered dopamine activity and social anxiety disorder

Researchers find link between altered dopamine activity and social anxiety disorder

Using single-photon emission computed tomography (SPECT), researchers in The Netherlands were able to detect biochemical differences in the brains of individuals with generalized social anxiety disorder (also known as social phobia), providing evidence of a long-suspected biological cause for the dysfunction. [More]
Genetic variations increase risk of anxiety disorders

Genetic variations increase risk of anxiety disorders

Massachusetts General Hospital (MGH) researchers - in collaboration with scientists at the University of California at San Diego and Yale University - have discovered perhaps the strongest evidence yet linking variation in a particular gene with anxiety-related traits. [More]
What's wrong with being shy?

What's wrong with being shy?

What's wrong with being shy, and just when and how did bashfulness and other ordinary human behaviors in children and adults become psychiatric disorders treatable with powerful, potentially dangerous drugs?, asks a Northwestern University scholar in a new book that already is creating waves in the mental health community [More]
Panic attacks may increase risk of heart attack or stroke in older women

Panic attacks may increase risk of heart attack or stroke in older women

Older women who experience at least one full-blown panic attack may have an increased risk of having a heart attack or stroke and an increased risk of death in the next five years, according to a report in the October issue of Archives of General Psychiatry, one of the JAMA/Archives journals. [More]
New screening tool for anxiety disorders

New screening tool for anxiety disorders

A new study by researchers led by Kurt Kroenke, M.D., of the Indiana University School of Medicine and the Regenstrief Institute, Inc. reports that nearly 20 percent of patients seen by primary care physicians have at least one anxiety disorder. [More]
D-cycloserine helps patients learn how to conquer their fears

D-cycloserine helps patients learn how to conquer their fears

The fear of public speaking is the most common among individuals with SAD, as well as in the general population. The results of the study are published in the March issue of the Archives of General Psychiatry. [More]

GlaxoSmithKline announces availability of Paxil CR to U.S. market

GlaxoSmithKline announced today the availability of Paxil CR (paroxetine hydrochloride controlled release) tablets in pharmacies across the United States. Other markets will follow shortly thereafter. [More]
Social anxiety disorder patients may be avoiding their doctor

Social anxiety disorder patients may be avoiding their doctor

Patients with social anxiety disorder are less likely to visit their primary care doctors than people with other psychiatric disorders like depression, or patients without mental health disorders, according to new research in the journal General Hospital Psychiatry. [More]
Second-generation Antidepressants

Second-generation Antidepressants

A recent article in the prestigious British Medical Journal seems to confirm an increased risk for suicidal behavior among adults taking popular antidepressants. This follows evidence that certain selective serotonin reuptake inhibitors (SSRIs) may have a similar effect among children and adolescents. [More]